These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8350405)

  • 1. Maturation of dimeric viral RNA of Moloney murine leukemia virus.
    Fu W; Rein A
    J Virol; 1993 Sep; 67(9):5443-9. PubMed ID: 8350405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
    Fu W; Gorelick RJ; Rein A
    J Virol; 1994 Aug; 68(8):5013-8. PubMed ID: 8035501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immature retroviral RNA genome resembles a kinetically trapped intermediate state.
    Grohman JK; Gorelick RJ; Kottegoda S; Allbritton NL; Rein A; Weeks KM
    J Virol; 2014 Jun; 88(11):6061-8. PubMed ID: 24623442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV.
    Roy C; Tounekti N; Mougel M; Darlix JL; Paoletti C; Ehresmann C; Ehresmann B; Paoletti J
    Nucleic Acids Res; 1990 Dec; 18(24):7287-92. PubMed ID: 2259624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization.
    Song R; Kafaie J; Yang L; Laughrea M
    J Mol Biol; 2007 Aug; 371(4):1084-98. PubMed ID: 17599354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA.
    Prats AC; Roy C; Wang PA; Erard M; Housset V; Gabus C; Paoletti C; Darlix JL
    J Virol; 1990 Feb; 64(2):774-83. PubMed ID: 2153242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.
    Crawford S; Goff SP
    J Virol; 1985 Mar; 53(3):899-907. PubMed ID: 3882995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-directed DNA synthesis in Moloney murine leukemia virus: interaction between the primer tRNA and the genome RNA.
    Peters G; Dahlberg JE
    J Virol; 1979 Aug; 31(2):398-407. PubMed ID: 480476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary structure of the mature ex virio Moloney murine leukemia virus genomic RNA dimerization domain.
    Gherghe C; Leonard CW; Gorelick RJ; Weeks KM
    J Virol; 2010 Jan; 84(2):898-906. PubMed ID: 19889760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations at the capsid-nucleocapsid cleavage site of gag polyprotein of Moloney murine leukemia virus abolish virus infectivity.
    Housset V; Darlix JL
    C R Acad Sci III; 1996 Feb; 319(2):81-9. PubMed ID: 8680959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition.
    D'Souza V; Melamed J; Habib D; Pullen K; Wallace K; Summers MF
    J Mol Biol; 2001 Nov; 314(2):217-32. PubMed ID: 11718556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
    J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
    Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
    J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Gag mutation and processing on retroviral dimeric RNA maturation.
    Fu W; Dang Q; Nagashima K; Freed EO; Pathak VK; Hu WS
    J Virol; 2006 Feb; 80(3):1242-9. PubMed ID: 16415001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection.
    Crawford S; Goff SP
    J Virol; 1984 Mar; 49(3):909-17. PubMed ID: 6608006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent.
    Prats AC; Housset V; de Billy G; Cornille F; Prats H; Roques B; Darlix JL
    Nucleic Acids Res; 1991 Jul; 19(13):3533-41. PubMed ID: 1906602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of blocking individual maturation cleavages in murine leukemia virus gag.
    Oshima M; Muriaux D; Mirro J; Nagashima K; Dryden K; Yeager M; Rein A
    J Virol; 2004 Feb; 78(3):1411-20. PubMed ID: 14722296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
    Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
    J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon.
    Aboud M; Kimchi R; Bakhanashvili M; Salzberg S
    J Virol; 1981 Dec; 40(3):830-8. PubMed ID: 6172601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.